List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 45 studies with search of:   "Liposarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Brostallicin Clinical Trial for Myxoid Liposarcoma
Condition: Myxoid Liposarcoma
Intervention: Drug: Brostallicin
2 Recruiting A Study of the Safety and Effectiveness of Trabectedin for the Treatment of Localized Myxoid / Round Liposarcoma
Condition: Liposarcoma, Myxoid
Intervention: Drug: Trabectedin, Yondelis
3 Active, not recruiting A Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Interventions: Drug: Yondelis;   Drug: Yondelis
4 Recruiting An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Conditions: Ovarian Neoplasms;   Colorectal Neoplasms;   Melanoma;   Small Cell Lung Cancer;   Liposarcoma
Interventions: Radiation: Ionizing radiation (IR) therapy;   Radiation: Ionizing radiation (IR)
5 Recruiting Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Condition: Sarcoma
Intervention: Drug: nelfinavir mesylate
6 Active, not recruiting Troglitazone in Treating Patients With Liposarcoma
Condition: Sarcoma
Intervention: Drug: troglitazone
7 Active, not recruiting Rosiglitazone in Treating Patients With Liposarcoma
Condition: Sarcoma
Intervention: Drug: rosiglitazone maleate
8 Recruiting Bevacizumab and Radiation Therapy for Sarcomas
Conditions: Soft Tissue Sarcoma;   Fibrous Histiocytoma;   Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma;   Synovial Sarcoma
Interventions: Drug: Bevacizumab;   Procedure: Radiation Therapy
9 Recruiting Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
Conditions: Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma
Intervention: Drug: Sunitinib Malate (SUTENT, SU011248)
10 Active, not recruiting Study of AP23573, an mTOR Inhibitor, in Patients With Advanced Sarcoma
Conditions: Leiomyosarcoma;   Liposarcoma;   Osteosarcoma;   Sarcoma, Soft Tissue;   Metastases
Intervention: Drug: AP23573
11 Active, not recruiting Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: celecoxib;   Procedure: adjuvant therapy;   Procedure: radiation therapy
12 Active, not recruiting Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Stromal Tumor;   Sarcoma
Interventions: Drug: sargramostim;   Drug: telomerase: 540-548 peptide vaccine
13 Recruiting Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: observation;   Procedure: radiation therapy;   Procedure: therapeutic conventional surgery
14 Recruiting Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: cixutumumab;   Drug: doxorubicin hydrochloride
15 Active, not recruiting Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Condition: Tumor
Interventions: Drug: belinostat;   Drug: 5-Fluorouracil (5-FU)
16 Recruiting Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Solid Tumor;   Lymphoma
Intervention: Drug: belinostat
17 Completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate
18 Active, not recruiting Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide
19 Completed Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Intervention: Drug: imatinib mesylate
20 Active, not recruiting Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services